Position in VIR
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$3,775,132
+$1,328,775 QoQ
Shares Held
421,332
+3.9% QoQ
Ownership
0.250%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 0%
Shared 92%
None 8%
Common Shares in VIR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Invesco Ltd. holds $8,194,153,126 across 259 Biotechnology names. VIR ranks #89 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,724,478 | $1,332,400,669 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,561,057 | $1,143,614,384 | |
| 3 | ARGX |
Argenx SE
|
594,697 | $434,277,482 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,291,726 | $427,393,371 | |
| 5 | INCY |
Incyte Corp
|
3,870,764 | $364,316,298 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
4,592,814 | $341,062,362 | |
| 7 | INSM |
INSMED Inc
|
1,988,968 | $325,236,040 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
4,012,494 | $259,327,483 |
All Filings in VIR
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,775,132 | 421,332 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $2,446,357 | 405,698 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $2,386,527 | 417,956 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,040,452 | 404,852 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $2,628,156 | 405,580 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $2,926,984 | 398,772 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $2,967,521 | 396,198 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $3,703,252 | 416,096 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $4,547,961 | 448,960 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $2,917,568 | 290,017 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $4,268,510 | 455,551 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $10,810,785 | 440,717 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $11,525,814 | 495,308 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $12,559,478 | 496,226 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $9,754,636 | 505,946 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $12,369,758 | 485,660 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,033,633 | 40,188 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $7,670,624 | 183,201 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,523,547 | 35,008 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,479,390 | 31,290 | Shares | Defined | 2021-08-17 | |
| 2021-03-31 | $891,994 | 17,398 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $306,309 | 11,438 | Shares | Defined | 2021-02-16 | |
| 2020-06-30 | $975,249 | 23,804 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||